Lowering the recommended age for colorectal cancer screening has led to a significant rise in screening rates among US adults aged 45 to 49, with early-stage diagnoses nearly doubling.
BP's strong Q2 performance driven by robust refining margins and oil trading despite lower oil and gas prices, leading to a dividend increase and ongoing portfolio reviews.
Lowering the recommended age for colorectal cancer screening has led to a significant rise in screening rates among US adults aged 45 to 49, with early-stage diagnoses nearly doubling.
BP's strong Q2 performance driven by robust refining margins and oil trading despite lower oil and gas prices, leading to a dividend increase and ongoing portfolio reviews.